CIB Marine Bancshares, Inc. (OTCQB: CIBH) recently filed
CIB Marine Bancshares, Inc. (OTCQB: CIBH) recently filed with the federal banking regulators its quarterly
regulatory financial reports through the first three months of 2013. CIB Marine and its subsidiary CIBM Bank
both reported earnings , improved capital ratios and other positive trends for the quarter.
Results of Operations - Summary
Earnings from operations for the first quarter of 2013 were $34,000 compared to a loss of $111,000 for the same
period of 2012. Both basic and diluted net incomes per share of common stock were nominal compared to a loss
per share of $0.01 for the same period of 2012.
? The improvement in earnings was primarily related to lower noninterest expense and improved noninterest
income more than offsetting a decline in net interest income.
? Net interest income declined by $1.0 million from $4.8 million in the first quarter of 2012 to $3.8 million in
the same period of 2013. The decline was primarily the result of a decline in yields on earning assets of 76
basis points versus a 21 basis point decline in the cost of interest bearing liabilities. The decline in earning
asset yields was a result of declines in the yields for both loan and securities.
? Noninterest income increased $0.7 million during the first quarter of 2013 compared to the same period in
2012 from a loss of $0.3 million during the first quarter of 2012 to income of $0.4 million in the same
period of 2013. The improvement was primarily related to net gains on securities and other real estate
owned in the first quarter of 2013 compared to other-than-temporary impairment from securities and losses
in other real estate owned in the first quarter of 2012.
? Noninterest expense improved $0.5 million during the first quarter of 2013 compared to the same period in
2012 from $4.6 million during the first quarter of 2012 to $4.1 million in the same period of 2013. The
decline was primarily the result of lower federal deposit insurance and reduced professional service
expenses, but also lower expenses for compensation and employee benefits, insurance and occupancy.
Financial Condition - Summary
During the first three months of 2013, CIB Marine showed improvement compared to one year ago in certain key
asset quality and capital measures. In addition to stronger regulatory capital ratios, the book value per share of
common stock was $0.42 at March 31, 2013, compared to $0.29 at March 31, 2012. Total assets have declined by
$33 million over the same time period, primarily the result of reductions in loan portfolio balances, some of which
were lower quality assets.
? The March 31, 2013, Tier 1 leverage ratio for CIB Marine improved to 14.67% from 13.49% at March 31,
2012 and 14.39% at December 31, 2012.
? Non-accrual loans were $11.4 million at March 31, 2013, an improvement from the $15.5 million reported
at March 31, 2012, but up from the $8.9 million reported at December 31, 2012. Other real estate owned
was $10.4 million compared to $8.0 million reported at March 31, 2012, and $10.5 million at December 31,
2012.
? Net charge-offs annualized to average loans increased to 2.81% during the first quarter of 2013, compared
to 0.12% during the same period of 2012. The rise in net charge-offs was primarily the result of a few
commercial real estate loan charge-offs during the first quarter of 2013 compared to significant recoveries
of previously charged off purchased home equity and commercial real estate loans during the first quarter of
2012.
CIB Marine Bancshares, Inc. (CIBH) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Top 5 Most Recently Viewed Articles
Box to Box Films Teams with Berk Communications for Strategic Growth The production studio selects sports and entertainment leader to elevate its voice across culture, sport, and entertainment. Supporting a New Era for Box to Box Films As the company enters a critical phase of growth, its portfolio continues to broaden, embracing a variety of formats and collaborators....
Continue Reading
Cryptocurrency Markets on the Rise The cryptocurrency markets experienced a notable recovery recently, with various altcoins rallying alongside Bitcoin. Ethereum emerged as a leading force in this resurgence, significantly impacting the market dynamics. Current Pricing Overview Here's a snapshot of some prominent cryptocurrencies: Bitcoin (BTC): Trading at $119,157.24...
Continue Reading
Understanding AbbVie's Bullish Sentiment Among Investors Investors are demonstrating considerable confidence in AbbVie (NYSE: ABBV) as they engage in bullish trading behaviors. This indicates a strong belief that the stock will perform positively in the near future, suggesting that investors may be anticipating significant developments or outcomes related to the company....
Continue Reading
Exciting New Chapter for Echandia in Sustainable Maritime Solutions Echandia, a pioneering force in advanced maritime battery systems, is making headlines with a significant contract to provide a 3.7 MWh battery system for a new hybrid icebreaker being constructed for the Canadian Coast Guard. This contract signifies a momentous step into the Canadian market, amplifying...
Continue Reading
Short Interest Snapshot: What’s the Shift? Looking at Moolec Science SA (NYSE: MLEC), short interest is a hot topic—like watching the stock market over a diner breakfast. It’s been a rollercoaster, folks. That short interest as a percent of float has taken a dive—down a hefty 36.93% since the last report. Let me spell it out: 23 thousand shares are sold short,...
Continue Reading